AlphaFold predicted structure
LSM7 · Q9UK45

Mean pLDDT
89.4/ 100
Confident
103 residues
Confidence breakdown
- Very high(≥ 90)70%
- Confident(70–90)19%
- Low(50–70)8%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
Annotations refreshed 10 hours ago.
Moderate Evidence (Amber)
Ataxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalChildhood onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalneurodegenerative disease
leukodystrophy
LSM7-related leukodystrophy and cerebellar atrophy
Joubert syndrome 36
hepatocellular carcinoma
neoplasm
breast cancer
breast carcinoma
Cerebellar atrophy
cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
U6 snRNA-associated Sm-like protein LSm7
Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex) (PubMed:28781166, PubMed:35047835). The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA (PubMed:10523320)
LSM7 · Q9UK45

Mean pLDDT
89.4/ 100
Confident
103 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0